Skip to main content

Table 2 Clinical characteristics of the 30 patients in the control group

From: Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy

No.

Gender

GMFCS stage

Age (years)

LDQ

GMFM

1

Female

V

1

72

36

2

Female

III

2.5

35

183

3

Male

III

3.5

28

198

4

Male

III

4

92

211

5

Male

V

2

100

35

6

Male

V

2

38

23

7

Male

V

4.5

15

33

8

Male

IV

3.5

27

110

9

Female

V

2

75

51

10

Female

IV

2.5

82

99

11

Male

IV

1

60

80

12

Female

III

15

95

201

13

Female

III

1

62

135

14

Male

IV

5

86

110

15

Female

IV

2.5

95

98

16

Male

IV

21

98

135

17

Male

IV

35

82

90

18

Male

IV

9

80

112

19

Female

V

4

12

30

20

Female

V

1

23

43

21

Male

V

1.7

25

45

22

Female

V

1

30

50

23

Female

III

1.5

80

146

24

Female

V

3

39

25

25

Male

IV

2.5

96

99

26

Male

V

2.6

100

28

27

Female

III

2

86

100

28

Female

V

1

65

45

29

Male

III

1.5

85

125

30

Male

V

1

64

43

  1. The clinical characteristics of the 30 patients in the control group are shown. GMFCS: Gross Motor Function Classification System levels; LDQ: language developmental quotient; GMFM: Gross Motor Function Measurement scores.